Tenax Therapeutics (TENX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts TENX Hot Sheet
Join SI Premium – FREE
Tenax Therapeutics (NASDAQ: TENX) reported Q3 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Regional Director in US Adjusts List of Top Names
- Raymond James Upgrades CVB Financial (CVBF) to Outperform
- Evercore ISI Upgrades Werner Enterprises (WERN) to In Line
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
